Author:
Cousien Anthony,Leclerc Pascale,Morissette Carole,Bruneau Julie,Roy Élise,Tran Viet Chi,Yazdanpanah Yazdan,Cox Joseph
Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011;378(9791):571–83.
2. Leclerc P, Vandal AC, Fall A, Bruneau J, Roy E, Brissette S, et al. Estimating the size of the population of persons who inject drugs in the island of Montreal, Canada, using a six-source capture-recapture model. Drug Alcohol Depend. 2014;142:174–80.
3. Leclerc P, Morissette C, Tremblay C, et al. Le volet montréalais du Réseau SurvUDI. Volume 3 – Données au 31 mars 2011 Montréal (QC): Direction de santé publique –Agence de la santé et des services sociaux de Montréal; 2013.
4. Myles A, Mugford GJ, Zhao J, Krahn M, Wang PP. Physicians’ attitudes and practice toward treating injection drug users with hepatitis C: results from a national specialist survey in Canada. Can J Gastroenterol. 2011;25(3):135–9.
5. Moirand R, Bilodeau M, Brissette S, Bruneau J. Determinants of antiviral treatment initiation in a hepatitis C-infected population benefiting from universal health care coverage. Can J Gastroenterol. 2007;21(6):355–61.